Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

 

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity
Avatar

Immunologic Basis of Adverse Events: Does Immunosuppression Used for Therapy of irAEs Compromise Anti-tumoral Immunity?

By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
332 views
March 24, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
It Isn’t Just Joint Pain
21:50

Adverse Events - Immunobiology of CPIs and Autoimmunity: PD-1 Pathwa…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

L. Calabrese

37 views
16:28

Immunologic Basis of Adverse Events: Does Immunosuppression Used for…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

L. Calabrese

332 views
09:52

Prospects of Targeted Therapy for Adverse Events: TNF, IL6, and T Ce…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

L. Calabrese

248 views
19:05

Rheumatic Immune Related Adverse Events from CPIs: Current and New T…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

C. Calabrese

15 views
18:50

62 y/o Male With Stage IV Renal Cell Carcinoma: Managing Rheumatic I…

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

E. Kirchner, C. Calabrese, L. Calabrese

22 views